Leridistim is under investigation in clinical trial NCT00004215 (Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia).
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Cyclophosphamide | The risk or severity of pulmonary toxicity can be increased when Leridistim is combined with Cyclophosphamide. |
| Vindesine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vindesine. |
| Vinorelbine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vinorelbine. |
| Vincristine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vincristine. |
| Vinblastine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vinblastine. |
| Vintafolide | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vintafolide. |
| Vinflunine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vinflunine. |
| Vincamine | The risk or severity of peripheral neuropathy can be increased when Leridistim is combined with Vincamine. |